Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport Long-term Extension in Cervical Dystonia
NCT00288509Phase 3Completed
- Sponsor
- Ipsen
- Start
- Feb 2006
- Primary completion
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of abobotulinumtoxinA in cervical dystonia (CD), sponsored by Ipsen. Started Feb 2006; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT00288509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288509.